EVAX Q1 2025 Earnings — Evaxion Biotech A/S Revenue & Financial Results | Market Cap Arena

EVAXEvaxion Biotech A/S

$20M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$4M

Net Income

-$2M

EPS (Diluted)

$-0.50

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

$0

Free Cash Flow

$0

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$25M

Total Liabilities

$15M

Stockholders' Equity

$10M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$51,000	-100.0%
Gross Profit	$0	$51,000	-100.0%
Operating Income	-$4M	-$4M	+12.0%
Net Income	-$2M	$1M	-232.3%